ALBEcef-CL-LB
Description_Effects
ALBEcef-CL-LB is a combination antibiotic formulation containing Cefixime 200mg, Cloxacillin 500mg, and Lactic Acid Bacillus 90 million spores (LAB). It is used to treat a wide range of bacterial infections, particularly those involving the respiratory tract, urinary tract, skin, and soft tissues. Cefixime is a third-generation cephalosporin antibiotic that works by disrupting the formation of bacterial cell walls, thereby killing the bacteria. Cloxacillin is a penicillinase-resistant penicillin that is especially effective against beta-lactamase-producing Gram-positive organisms, including Staphylococcus aureus. The addition of Lactic Acid Bacillus helps maintain the balance of beneficial bacteria in the gut, reducing the risk of antibiotic-associated diarrhea and other gastrointestinal disturbances. This combination therapy offers broad-spectrum antibacterial coverage, making it suitable for mixed or resistant infections. It is typically prescribed by healthcare professionals and should be taken as directed to ensure effective treatment and to prevent the development of antibiotic resistance. Common side effects may include nausea, vomiting, abdominal discomfort, or mild allergic reactions. It should not be used by individuals with known allergies to penicillins or cephalosporins and should be used cautiously in patients with kidney or liver disorders. Completing the full prescribed course is essential, even if symptoms improve early.
